Related Experiment Video
Updated: Jul 19, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat
1Department of Physiology, School of Medicine, Tehran University of Medical Sciences, 14174 Tehran, Iran.
Abstract:
Different nitric oxide synthase (NOS) isoforms are found in the kidney. Some studies provided evidences that increased endothelial NOS (eNOS) activity leads to restoration of renal function after injury, but activation of inducible NOS (iNOS) aggravates renal failure. In the present study, the beneficial effects of selective iNOS blockade in gentamicin (GM) induced nephrotoxicity have been investigated. Four groups of rats were studied. Untreated control rats received saline. In GM group, GM was injected (IV, 4 mg kg(-1)). In GM + L-NAME group rats received L-NAME (N-omega-L-arginine methyl ester, a non-selective NOS inhibitor) simultaneously with GM (IV, 30 mg kg(-1)). Additional doses of L-NAME were administered 2 and 4 h after GM (IP, 30 mg kg(-1)). In GM + L-NIL group rats were treated by N-imino-ethyl lysine (L-NIL, a selective iNOS inhibitor). First dose (IV, 3 mg kg(-1)) administrated simultaneously with GM. Next doses (IP, 3 mg kg(-1)) were administered 2 and 4 h after GM. In all groups, serum and urine creatinine levels were measured. Creatinine clearance was calculated and considered as an estimation of glomerular filtration rate (GFR). Urine N-acetyl-b-D-glucose aminidase (NAG) activities were also determined. After experiments, kidney sections were histologically studied. Selective iNOS inhibition by L-NIL prevented the GM-induced decrease in GFR and increase in creatinine levels, while complete non-selective NOS inhibition by L-NAME aggravated the GFR reduction, elevation of creatinine levels and enzyme release (P < 0.05). Histological studies showed that GM-treated kidneys had evidences of tubular damages and these damages were less evident by the administration of L-NIL. In conclusion, selective inhibition of iNOS may prevent GM-induced nephrotoxicity, whereas non-selective inhibition of NOS aggravates it.
Insights
Selective inhibition of inducible nitric oxide synthase (iNOS) protects against gentamicin-induced nephrotoxicity. Blocking all nitric oxide synthase (NOS) isoforms, however, worsens kidney injury, highlighting iNOS as a therapeutic target.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Nitric oxide synthase (NOS) isoforms play differential roles in kidney injury.
- Endothelial NOS (eNOS) activity can restore renal function, while inducible NOS (iNOS) activation exacerbates kidney failure.
Purpose of the Study:
- To investigate the protective effects of selective inducible NOS (iNOS) blockade against gentamicin (GM)-induced nephrotoxicity in rats.
Main Methods:
- Rats were divided into four groups: control, GM-only, GM + non-selective NOS inhibitor (L-NAME), and GM + selective iNOS inhibitor (L-NIL).
- Renal function was assessed by measuring serum creatinine, creatinine clearance (as a marker of glomerular filtration rate - GFR), and urine N-acetyl-b-D-glucose aminidase (NAG) activity.
- Kidney tissues were examined histologically for tubular damage.
Main Results:
- Selective iNOS inhibition with L-NIL prevented the decrease in GFR and increase in creatinine caused by GM.
- Non-selective NOS inhibition with L-NAME worsened GM-induced nephrotoxicity, including reduced GFR, elevated creatinine, and increased enzyme release.
- Histological analysis revealed reduced tubular damage in rats treated with L-NIL compared to GM-only or GM + L-NAME groups.
Conclusions:
- Selective inhibition of iNOS demonstrates a protective effect against gentamicin-induced nephrotoxicity.
- Non-selective NOS inhibition exacerbates kidney injury, underscoring the specific detrimental role of iNOS in this model.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators

